Company Filing History:
Years Active: 2014-2016
Title: Innovator Spotlight: Ursula Schlosser from Uttendorf, Austria
Introduction: Ursula Schlosser is a notable inventor based in Uttendorf, Austria, recognized for her significant contributions to the field of pharmaceutical compositions. With a total of two patents to her name, her innovations are paving the way for advancements in targeted drug delivery systems.
Latest Patents: Ursula has developed two related patents focused on IC31 nanoparticles. The invention describes pharmaceutical compositions in liquid form that comprise a peptide with the amino acid sequence KLKLKLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC). In these compositions, both the peptide and oligodeoxynucleotide are present as sterile-filterable nanoparticles, resulting in a suspension characterized by a mean particle size of less than 1 μm. These innovative nanoparticles hold promise for enhanced efficacy and precision in therapeutic applications.
Career Highlights: Ursula is currently employed at Valneva Austria GmbH, a company dedicated to developing innovative vaccines and treatments. Her work reflects a strong commitment to scientific research and the advancement of healthcare solutions through groundbreaking inventions.
Collaborations: Throughout her career, Ursula has had the opportunity to collaborate with notable coworkers, including Benjamin Wizel and Karin Riedl. These partnerships highlight the collaborative spirit prevalent in scientific research and the importance of teamwork in achieving successful innovations.
Conclusion: Ursula Schlosser's contributions to the field of pharmaceuticals are marked by her innovative work on IC31 nanoparticles. Her patents showcase the potential for significant advancements in drug delivery systems, positioning her as a notable figure in the realm of inventions and innovations. The collaborative efforts with her colleagues further emphasize the importance of teamwork in driving scientific progress.